CD44 exerts a functional role during EMT induction in cisplatin-resistant head and neck cancer cells.

Miyazaki, Hiroaki; Takahashi, Ryou-U; Prieto-Vila, Marta; Kawamura, Yumi; Kondo, Seiji; Shirota, Tatsuo; Ochiya, Takahiro

Miyazaki, Hiroaki; Takahashi, Ryou-U; Prieto-Vila, Marta; Kawamura, Yumi; Kondo, Seiji; Shirota, Tatsuo; Ochiya, Takahiro.

Afiliación

Miyazaki H; Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Takahashi RU; Department of Oral and Maxillofacial Surgery, Showa University School of Dentistry, Tokyo 145-8515, Japan.
Prieto-Vila M; Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Kawamura Y; Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Kondo S; Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Shirota T; Ph.D. Program in Human Biology, School of Integrative and Global Majors, University of Tsukuba 1-1-1 Tennodai, Ibaraki 305-8577, Japan.
Ochiya T; Department of Oral and Maxillofacial Surgery, Showa University School of Dentistry, Tokyo 145-8515, Japan.

Oncotarget ; 9(11): 10029-10041, 2018 Feb 09.

Article en En | MEDLINE | ID: mdl-29515788

Palabras clave

CD44; EMT; cancer stem cell niche; oral cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google